A Study of MRG002 in the Treatment of Patients With HER2-positive Advanced Solid Tumors

NCT04941339 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

74

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

DRUG: MRG002

Sponsor

Shanghai Miracogen Inc.